SLC38A7 and triple-negative breast carcinoma: We undertook the present investigation to determine the potential crosstalk between two specific amino acid transporters in triple-negative breast cancer (TNBC) in enhancing the antioxidant machinery and to identify an effective pharmacologic strategy to interfere with this pathway as a plausible anticancer approach.